Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

The FDA Reversed A 20-Year Warning On Hormone Therapy And Now The Demand Has Changed Everything

For decades, millions of women going through menopause were told to avoid hormone replacement therapy based on a 2002 study that linked estrogen use to elevated risks of heart attack and stroke, and prescriptions plummeted. Last year, the FDA reversed course, removing the longstanding black box warning from estrogen products and publicly promoting hormone therapy for appropriate patients after evolving evidence showed that the original conclusions were tied to the specific oral formulations used in that study and did not apply to the transdermal patches and gels that have become the standard of care. The result has been a surge in demand so significant that pharmacies across the country are struggling to keep estrogen patches on shelves, with industry sources telling Reuters that shortages could last up to three years as manufacturers race to scale production. More than one million women in the United States enter menopause every year.

Into that gap has stepped Hims and Hers, the telehealth company, which announced this week that it has secured a steady supply of estrogen patches and will now offer personalized menopause and perimenopause treatment plans through its Hers platform, with patch kits starting at $134 per month. Patients connect with licensed providers trained specifically in menopause care, can adjust their treatment plans over time, and have access to a round-the-clock care team and educational resources through the Hers app. The expansion follows a broader cultural shift in which physicians, researchers, and patients are increasingly refusing to accept that the symptoms of menopause, which can include debilitating hot flashes, night sweats, and disrupted sleep, are simply something women must endure without effective treatment. The FDA reversal, the shortage, and the wave of new providers entering the space all point in the same direction: the era of menopause care being treated as an afterthought may finally be ending.

Source: https://www.reuters.com/legal/litigation/hims-hers-expands-into-menopause-care-estrogen-patch-demand-rises-2026-04-22/

PrevPreviousFive Middle Schoolers Just Took Control Of A Bus After Their Driver Blacked
NextThis Record Holding Martial Arts Star Just Popped 35 Balloons With Her HeelNext

Recent Articles

Happy News

For The First Time In History Medicare Is Covering Weight Loss Drugs And The Price Is $50 A Month

May 14, 2026

Starting July 1, 2026 eligible Medicare enrollees will be able to access GLP-1 weight loss medications including Wegovy, Zepbound, and the newer drug Foundayo for a flat $50 monthly copay, in a historic first for the program, which has never before covered anti-obesity medications despite covering many of the serious

Read More
Happy News

Swedish Scientists Just Grew The Cells Type 1 Diabetes Destroys From Scratch

May 13, 2026

Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a more reliable method for growing insulin-producing cells from human stem cells, and the results published in Stem Cell Reports represent one of the most encouraging steps yet toward a potential treatment for type 1 diabetes.

Read More
Happy News

New Research Reveals The Personality Trait That Predicts Whether You Will Seek Out A Cat When Stressed

May 12, 2026

A study published in the journal Anthrozoös, conducted by researchers at Washington State University and KU Leuven in Belgium, has identified the personality trait most likely to predict whether someone will seek out a cat for stress relief rather than a dog, and the answer has a name: emotionality. Researchers

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.